You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias

    SBC: Path Biotech, LLC            Topic: NIA

    PROJECT SUMMARY/ABSTRACT In response to National Institute on Aging's (NIA) strategic plan and PAS-19-317, we propose novel therapeuticsto treat Alzheimer disease and related dementias (ADRDs). We have developed novel combinations of three natural product compounds, which modulate complementary pathways in multiple types of CNS cells (i.e., neurons, microglia) associated with AD pathology. These c ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. ICU-CARE: An interactive mobile app to enhance the efficiency of daily informal caregiving in the intensive care unit

    SBC: SILICON CURES LLC            Topic: NINR

    PROJECT SUMMARY Actively involving informal caregivers in direct patient care at the bedside in the intensive care unit (ICU) has the potential to improve patient, informal caregiver, and health care system outcomes. Practice guidelines call for the liberal inclusion of informal caregivers as active partners in ICU care, but there is a critical, unmet need to develop tools that effectively operati ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Developing a new aspiration catheter solution for the treatment of large and medium vessel occlusions

    SBC: ANEUVAS TECHNOLOGIES INC            Topic: 104

    Project Summary/Abstract Stroke is the leading cause of serious long-term disability and accounts for 4.6 million disabled people in the United States. Stroke-related costs total over $46 billion in the United States each year.1 Of the nearly 800,000 Americans who have a stroke per year, 87% experience ischemic stroke1, of which 49%-86% are attributed to either large vessel occlusions (LVO) or med ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Biomarkers for Brain Resetting as an Assistive Tool in the Treatment of Status Epilepticus

    SBC: Epifocus LLC            Topic: 104

    The proposed phase-I STTR research is an interdisciplinary effort to develop more effective clinical management of Status Epilepticus (SE) in collaboration with one of the leading neurological institutes in the world, the Barrow Neurological Institute in Phoenix, Arizona. SE is a life-threatening neurological emergency that can occur without warning and is characterized by recurrent seizures witho ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Additive Manufacturing of Structural Insulators

    SBC: ADVANCED CERAMICS MANUFACTURING, LLC            Topic: MDA22T012

    There is a need for a lightweight, high-performance, insulation to protect the internal systems in hypersonic vehicles. A passive thermal protection system (TPS) design would be simple and reliable. As designs evolve, there is a need for TPS insulation materials that can be additively manufactured. Our Phase I approach will additively manufacture pre-ceramic scaffolds that are used to create low d ...

    STTR Phase I 2023 Department of DefenseMissile Defense Agency
  6. Paratemporal Simulation with Uncertainty Quantification

    SBC: RTSYNC CORP            Topic: MDA22T001

    We propose to develop Para-DEVS, an extension of the existing modeling and simulation (M&S) environment overcome two major hurdles that must be overcome to implement paratemporal simulation techniques for application to execution of large stochastic models. We propose to develop techniques to achieve scalability, the ability to overcome the combinatorial explosion of branching arising from multipl ...

    STTR Phase I 2023 Department of DefenseMissile Defense Agency
  7. Femtosecond Direct Diode Laser System (fsDDLS) to Enable Hypersonic Drag Reduction

    SBC: PHYSICS, MATERIALS, AND APPLIED MATHEMATICS RESEARCH L.L.C.            Topic: MDA22T006

    In the proposed effort, we will develop the fundamental building blocks to develop a high performance, low Size, Weight, and Power (SWaP) ultrashort pulse Femtosecond Direct Diode Laser System (fsDDLS) capable of generating and sustaining filaments/plasma channels in the atmosphere ahead of a vehicle in hypersonic flight to reduce drag, heating, and displace shock. Approved for Public Release | 22 ...

    STTR Phase I 2023 Department of DefenseMissile Defense Agency
  8. Large Form Factor Scintillators for Nuclear Battlefield Operations

    SBC: N.P. PHOTONICS, INC.            Topic: DTRA22D002

    The current state-of-the-art radiation detection materials have different drawbacks limiting their applications in the next-generation mobile radiation detection system. NP Photonics proposes to develop a novel scintillating glass that can be used to make large form-factor scintillators for nuclear battlefield operations. The proposed scintillating glass has the advantages of low cost, short decay ...

    STTR Phase I 2023 Department of DefenseDefense Threat Reduction Agency
  9. Modeling-Enhanced Survivability Testing (MEST) Strategy for Microelectronics

    SBC: ALPHACORE INC            Topic: MDA21T001

    Alphacore and Vanderbilt University will develop innovative, cost effective methodology and solutions for radiation testing of microelectronics, to evaluate and distinguish between radiation effects from a persistent beta environment and a persistent gamma environment, and determine the circumstances where testing for one environment is sufficient to show survivability in the other, or in a combin ...

    STTR Phase I 2022 Department of DefenseMissile Defense Agency
  10. Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis

    SBC: Faknostics, LLC            Topic: NHLBI

    PROJECT ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and fatal fibrotic lung disorder which disproportionately affects men and the elderly. Although two drugs (pirfenidone and nintedanib) have recently gained FDA-approval for IPF and progressive fibrosing lung disorders related to connective tissue diseases (rheumatoid arthritis and scleroderma, more common in younger ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government